| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07558538 A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of… |
Recruitment opened |
| 2026-05-21 | NCT07587034 HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer |
Primary endpoint(s) modified |
| 2026-05-15 | NCT07358663 Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07640906 AI-Assisted Chest-CT Reporting for Enhanced Speed and Quality (The DOUBLE-ACE Study) | Not Yet Recruiting | |
| 2026-06-10 | NCT07638683 A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With… | Phase 2 | Recruiting |
| 2026-06-09 | NCT07634861 Evaluating a Text-Prompt AI Assistant for Chest CT Scans (AI-REPORT Study) | Recruiting | |
| 2026-06-05 | NCT07629921 Multimodal AI for Precision Diagnosis of Esophageal Cancer | Active, Not Recruiting | |
| 2026-06-04 | NCT07625735 MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis… | Not Yet Recruiting | |
| 2026-06-02 | NCT07621380 Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction | Phase 4 | Not Yet Recruiting |
| 2026-05-29 | NCT07613996 Impact of Hyperemic State on Angio-IMR Performance | Recruiting | |
| 2026-05-29 | NCT07614061 Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in… | Phase 1 | Recruiting |
| 2026-05-29 | NCT07616024 Intravascular Ultrasound guidaNce versuS angIoGrapHy Guidance in Patients With ST-segment… | Not Yet Recruiting | |
| 2026-05-29 | NCT07616037 Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06451198 | IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly… | Coronary Artery Disease | Recruiting |
| NCT07172451 | Gelaspan vs Crystalloid Therapy in Sepsis | Sepsis | Recruiting |
| NCT07307235 | Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China… | Type 2 Diabetes | Not Yet Recruiting |
| NCT07325357 | Effect of Pirfenidone on TA Fibrosis | Takayasu Arteritis | Not Yet Recruiting |
| NCT07405684 | Fecal Molecular Susceptibility-guided Hp First-line Therapy | HELICOBACTER PYLORI INFECTIONS | Not Yet Recruiting |
| NCT07405697 | Fecal Molecular Susceptibility-guided Hp Rescue Therapy | Helicobacter Pylori Infection | Not Yet Recruiting |
| NCT07621380 | Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction | Type 2 Diabetes Mellitus Myocardial Infarction | Not Yet Recruiting |
| Phase 3 | |||
| NCT07309289 | NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line… | Metastatic Colorectal Cancer (CRC) | Recruiting |
| NCT07320625 | Efficacy of Montelukast on STEMl Patients | Myocardial Infarction (MI) | Recruiting |
| NCT07479784 | Octreotide Microspheres for Preventing Pancreatic Fistula | Pancreatic Fistula | Not Yet Recruiting |
| NCT07508956 | Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant… | Gastric / Gastroesophageal Junction Adenocarcinoma | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07309419 | A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus… | Hepatocellular Carcinoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT06468280 | Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by… | Gastric Cancer | Recruiting |
| NCT07570849 | Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for… | Intrahepatic Cholangiocarcinoma | Recruiting |
| NCT07616037 | Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS | PCOS (Polycystic Ovary Syndrome) | Recruiting |
| NCT07638683 | A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With… | Multiple Myeloma | Recruiting |
| NCT07259473 | Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal… | Gastric / Gastroesophageal Junction Adenocarcinoma | Not Yet Recruiting |
| NCT07346807 | Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced… | Tongue Squamous Cell Carcinoma | Not Yet Recruiting |
| NCT07353476 | Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC | NSCLC (Advanced Non-small Cell Lung Cancer) | Not Yet Recruiting |
| NCT07266025 | Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch… | Gastric Adenocarcinoma | Not Yet Recruiting |
| NCT07501104 | Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage… | Melanoma (Skin Cancer) | Not Yet Recruiting |
| NCT07517653 | Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable… | Melanoma | Not Yet Recruiting |
| NCT07535632 | SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for… | Colorectal Neoplasms | Not Yet Recruiting |
| NCT07545083 | Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and… | Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07333573 | A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer | Stage IV Gastric Cancer | Not Yet Recruiting |